Last viewed: SRNE

Prices are updated after-hours

SRNE Nasdaq 2020 - 12 - 09

Sorrento Therapeutics, Inc.

SRNE | $0.028 -8.85% 42K

|

Health Technology

(0.0% 1d) (200.0% 1m) (-91.4% 1y) (0.0% 2d) (9.1% 3d) (0.0% 7d) (-20.53% volume)
Earnings Calendar: 2023-02-20
Market Cap: $ 15,435,872
http://www.sorrentotherapeutics.com
Sec Filling | Patents | 310 employees

(US) Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

cancer covid antibody t-cell ceiling

add to watch list Paper trade email alert is off

Press-releases

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
Published: 2024-03-27 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M

|

| -22.52% | O: -0.66% H: 10.33% C: 7.33%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| 233.33% | O: -11.11% H: 12.5% C: 0.0%
company

Virpax Pharmaceuticals Reports 2023 Year-End Results
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
VRPX | $3.87 11.53% 10.34% 20K

|

| -8.83% | O: -0.68% H: 3.17% C: 2.65%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| 233.33% | O: 11.11% H: 0.0% C: -10.0%
virpax pharmaceuticals results

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement
Published: 2024-03-15 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M

|

| -15.83% | O: 0.72% H: 2.89% C: -2.14%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| 114.29% | O: -7.14% H: 46.15% C: 38.46%
virpax wholly pharmaceuticals agreement

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
Published: 2024-03-02 (Crawled : 00:20) - globenewswire.com
SRNE | $0.028 -8.85% 42K

|

Health Technology

| Email alert Add to watchlist
SCLX | $0.8942 -23.57% -30.84% 2.8M

|

| Email alert Add to watchlist
company

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
VRPX | $3.87 11.53% 10.34% 20K

|

| 920.89% | O: -14.39% H: 7.35% C: -0.24%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| 7.14% | O: 7.14% H: 66.67% C: -11.0%
virpax pharmaceuticals

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
Published: 2024-02-26 (Crawled : 22:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M

|

| -43.48% | O: 1.45% H: 15.24% C: 10.0%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| 7.14% | O: 7.14% H: 66.67% C: -11.0%
virpax wholly pharmaceuticals agreement

Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M

|

Health Technology

| -10.59% | O: 0.39% H: 0.82% C: -0.74%
NVS | News | $92.57 -0.55% 0.0% 910K

|

Health Technology

| -13.6% | O: 0.22% H: 0.43% C: -0.39%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| 0.0% | O: -63.33% H: 263.64% C: 127.27%
GILD | $66.16 -1.15% -1.16% 6.4M

|

Health Technology

| -15.79% | O: 0.1% H: 0.43% C: -0.04%
AUTL | $4.8 -0.83% -0.83% 1.2M

|

Health Technology

| -11.96% | O: -0.91% H: 11.52% C: 4.94%
drug report t-cell global therapy market

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M

|

| -42.65% | O: 3.82% H: 5.76% C: 1.04%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| -73.57% | O: -2.03% H: 3.42% C: -1.08%
company

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
Published: 2023-11-17 (Crawled : 17:00) - biospace.com/
VRPX | $3.87 11.53% 10.34% 20K

|

| 388.18% | O: 6.92% H: 0.0% C: -7.88%
SRNE | $0.028 -8.85% 42K

|

Health Technology

| -42.86% | O: 0.0% H: 14.29% C: 3.05%
nasdaq virpax pharmaceuticals

UPDATE -- Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records from certain Brokers, Dealers, Banks and other Nominees Pursuant to Rule 2004 of the Federal Rules of Bankruptcy Procedure
Published: 2023-10-27 (Crawled : 20:00) - globenewswire.com
SRNE | $0.028 -8.85% 42K

|

Health Technology

| Email alert Add to watchlist
SCLX | $0.8942 -23.57% -30.84% 2.8M

|

| Email alert Add to watchlist
company update order

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | $1.02 155.0% 57.94% 120M

|

ZCMD | $2.86 108.76% 52.1% 2.3M

|

Commercial Services

INVO | $1.555 104.6% 51.13% 5M

|

Health Technology

ISPC | $0.437 105.16% 49.53% 37M

|

Professional, Scientific, and T...

WLGS | $0.92 84.0% 45.65% 1.6M

|

OST | $0.499 21.38% 45.26% 1.9M

|

XPON | $3.1 60.62% 37.74% 17M

|

TIRX | $0.7 44.39% 30.74% 58M

|

BNTC | $6.92 44.17% 30.64% 3.5M

|

Health Technology

GGE | $0.035 19.86% 29.3% 64M

|

Last 48 Hours Insiders Buying

SNDA P 3000 | $29.61 3.35% 0.0% 30K

|

| 22:00
AXR P 2400 | $22.17 2.69% 0.0% 5.5K

|

| 21:00
FAST P 3350 | $67.5 -1.43% -1.45% 3.6M

|

Distribution Services

| 20:00
QCRH | $55.405 1.33% 1.31% 54K

|

| 18:01
RVP P 15363 | $1.05 0.96% 0.0% 120K

|

Health Technology

| 18:00
VUZI | $1.26 3.28% 3.17% 1M

|

Electronic Technology

| 18:00
TPL P 3 | $582.4 -0.44% 0.0% 63K

|

| 15:00
RELL | $10.15 2.94% 2.86% 94K

|

Electronic Technology

| 13:30
IZEA | $2.65 4.74% 4.53% 31K

|

Technology Services

| 00:00
RKT P 383 | $11.53 1.32% 0.0% 1.6M

|

| 22:30
CTRN P 18090 | $22.28 -0.4% -0.4% 55K

|

| 22:00
BRN P 10650 | $2.8 0.36% -0.36% 54K

|

Energy Minerals

| 21:00
NEOG P 10000 | $11.94 -1.65% -1.68% 2.9M

|

Health Technology

| 16:30
RMCF | $3.61 2.27% 2.22% 18K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar